The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Harm Reduction

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Harm Reduction

  • CONCLUSIONS: Among drug users who receive methadone maintenance treatment in a harm-reduction setting, which includes ancillary services such as needle-exchange programmes and HIV testing and counselling, prescription of high methadone dosages is not sufficient to stop the spread of HIV [1].
  • A better understanding of the etiology of hyperthermia after MDMA use is needed so that appropriate harm-reduction measures can be developed and instituted [2].

Psychiatry related information on Harm Reduction


High impact information on Harm Reduction


Chemical compound and disease context of Harm Reduction


Biological context of Harm Reduction

  • The hypotheses advanced include: the changing nature of the industry's interest in research and the role of marketing; the rise of the 'new public health' alliance focused on abstention rather than on harm minimization; the role of government funding and control of research; and the changing meaning of tobacco and especially nicotine [18].
  • This article looks at the history, epidemiology, and politics of Ecstasy, the media's response, and the ways in which media and government reaction will compromise harm reduction and safety [19].

Gene context of Harm Reduction

  • In the current analysis, they compared African American and White students on indicators of high-risk drinking, drinking consequences, harm-reduction strategies, the sources that students typically used for health information, and the believability of those sources [7].
  • The topic of drug consumption facilities or rooms (DCRs) was reviewed by Dolan, Kimber and others in Harm Reduction Digest 10, published in the September 2000 issue of DAR [20].
  • The 2001 Institute of Medicine report Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction has helped to focus attention on the scientific basis for assessing tobacco harm reduction products [21].

Analytical, diagnostic and therapeutic context of Harm Reduction


  1. Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study. Langendam, M.W., van Brussel, G.H., Coutinho, R.A., van Ameijden, E.J. AIDS (1999) [Pubmed]
  2. Methylenedioxymethamphetamine (ecstasy)-related hyperthermia. Patel, M.M., Belson, M.G., Longwater, A.B., Olson, K.R., Miller, M.A. The Journal of emergency medicine. (2005) [Pubmed]
  3. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study. Batra, A., Klingler, K., Landfeldt, B., Friederich, H.M., Westin, A., Danielsson, T. Clin. Pharmacol. Ther. (2005) [Pubmed]
  4. Pharmacological treatments for heroin and cocaine addiction. van den Brink, W., van Ree, J.M. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. (2003) [Pubmed]
  5. Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender. Puigdollers, E., Domingo-Salvany, A., Brugal, M.T., Torrens, M., Alvarós, J., Castillo, C., Magrí, N., Martín, S., Vázquez, J.M. Substance use & misuse. (2004) [Pubmed]
  6. Drug use and HIV/AIDS in China. Liu, Z., Lian, Z., Zhao, C. Drug and alcohol review. (2006) [Pubmed]
  7. Differences in African American and White college students' drinking behaviors: consequences, harm reduction strategies, and health information sources. Siebert, D.C., Wilke, D.J., Delva, J., Smith, M.P., Howell, R.L. Journal of American college health : J of ACH. (2003) [Pubmed]
  8. The bioavailability of intranasal and smoked methamphetamine. Harris, D.S., Boxenbaum, H., Everhart, E.T., Sequeira, G., Mendelson, J.E., Jones, R.T. Clin. Pharmacol. Ther. (2003) [Pubmed]
  9. Paracetamol self-poisoning. Characteristics, prevention and harm reduction. Hawton, K., Ware, C., Mistry, H., Hewitt, J., Kingsbury, S., Roberts, D., Weitzel, H. The British journal of psychiatry : the journal of mental science. (1996) [Pubmed]
  10. Fraction of free-base nicotine in fresh smoke particulate matter from the Eclipse "cigarette" by 1H NMR spectroscopy. Pankow, J.F., Barsanti, K.C., Peyton, D.H. Chem. Res. Toxicol. (2003) [Pubmed]
  11. Harm minimization in school drug education: final results of the School Health and Alcohol Harm Reduction Project (SHAHRP). McBride, N., Farringdon, F., Midford, R., Meuleners, L., Phillips, M. Addiction (2004) [Pubmed]
  12. Alcohol, tobacco and cannabis use among Nova Scotia adolescents: implications for prevention and harm reduction. Poulin, C., Elliott, D. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. (1997) [Pubmed]
  13. Early results from a school alcohol harm minimization study: the School Health and Alcohol Harm Reduction Project. McBride, N., Midford, R., Farringdon, F., Phillips, M. Addiction (2000) [Pubmed]
  14. Putting an Ecstasy test kit to the test: harm reduction or harm induction? Murray, R.A., Doering, P.L., Boothby, L.A., Merves, M.L., McCusker, R.R., Chronister, C.W., Goldberger, B.A. Pharmacotherapy (2003) [Pubmed]
  15. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: a qualitative study. Cooper, H., Moore, L., Gruskin, S., Krieger, N. Social science & medicine (1982) (2005) [Pubmed]
  16. Harm reduction for methamphetamine users. Kingston, S., Conrad, M. Focus (San Francisco, Calif.) (2004) [Pubmed]
  17. Effect of strategies to reduce exposure of infants to environmental tobacco smoke in the home: cross sectional survey. Blackburn, C., Spencer, N., Bonas, S., Coe, C., Dolan, A., Moy, R. BMJ (2003) [Pubmed]
  18. Why have attitudes to industry funding of research changed? Berridge, V. Addiction (1997) [Pubmed]
  19. Ecstasy: America's new "reefer madness". Rosenbaum, M. Journal of psychoactive drugs. (2002) [Pubmed]
  20. Drug consumption facilities: an update since 2000. Kimber, J., Dolan, K., van Beek, I., Hedrich, D., Zurhold, H. Drug and alcohol review. (2003) [Pubmed]
  21. Tobacco harm reduction: a call to address the ethical dilemmas. Fox, B.J., Cohen, J.E. Nicotine Tob. Res. (2002) [Pubmed]
  22. Eighth World Congress of Intensive and Critical Care Medicine, 28 October-1 November 2001, Sydney, Australia: Harm minimization and effective risk management. Ramakrishnan, N. Critical care (London, England) (2002) [Pubmed]
WikiGenes - Universities